# Immunosuppression After Repeat Keratoplasty

> **NCT04147390** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 58 (estimated)

## Conditions studied

- Keratopathy

## Interventions

- **DRUG:** prescribe topical 0.03 % tacrolimus
- **DRUG:** prescribe mycophenolate mofetil(MMF)

## Key facts

- **NCT ID:** NCT04147390
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11
- **Primary completion:** 2020-03
- **Final completion:** 2020-08
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147390, "Immunosuppression After Repeat Keratoplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04147390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*